Ovidiu C Andronesi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 37 | 2024 | 3765 | 4.890 |
Why?
|
Glutarates | 8 | 2021 | 244 | 3.200 |
Why?
|
Glioma | 16 | 2024 | 3420 | 2.720 |
Why?
|
Isocitrate Dehydrogenase | 13 | 2023 | 929 | 2.580 |
Why?
|
Brain Neoplasms | 26 | 2024 | 8985 | 1.930 |
Why?
|
Imaging, Three-Dimensional | 15 | 2024 | 4046 | 1.630 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 8 | 2013 | 511 | 1.210 |
Why?
|
Magnetic Resonance Imaging | 29 | 2022 | 36286 | 1.160 |
Why?
|
Brain | 24 | 2024 | 26951 | 1.110 |
Why?
|
Signal Processing, Computer-Assisted | 7 | 2016 | 1489 | 0.870 |
Why?
|
Echo-Planar Imaging | 3 | 2024 | 657 | 0.850 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2020 | 8950 | 0.760 |
Why?
|
gamma-Aminobutyric Acid | 6 | 2020 | 1132 | 0.740 |
Why?
|
Brain Chemistry | 5 | 2018 | 959 | 0.730 |
Why?
|
Consensus | 7 | 2023 | 3113 | 0.700 |
Why?
|
Motion | 4 | 2020 | 779 | 0.650 |
Why?
|
Molecular Imaging | 4 | 2016 | 818 | 0.570 |
Why?
|
Metabolome | 5 | 2020 | 982 | 0.500 |
Why?
|
Phantoms, Imaging | 8 | 2021 | 2512 | 0.480 |
Why?
|
Glioblastoma | 10 | 2021 | 3482 | 0.470 |
Why?
|
Water | 2 | 2021 | 1407 | 0.410 |
Why?
|
Image Enhancement | 4 | 2016 | 2881 | 0.410 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2020 | 3340 | 0.380 |
Why?
|
Mutation | 12 | 2023 | 29957 | 0.370 |
Why?
|
Spin Labels | 5 | 2016 | 336 | 0.370 |
Why?
|
Artifacts | 7 | 2018 | 1898 | 0.360 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2016 | 1660 | 0.350 |
Why?
|
Contrast Media | 5 | 2017 | 5305 | 0.330 |
Why?
|
Magnetite Nanoparticles | 1 | 2010 | 316 | 0.320 |
Why?
|
Dextrans | 1 | 2010 | 574 | 0.310 |
Why?
|
Transducers | 1 | 2010 | 240 | 0.310 |
Why?
|
Wound Infection | 1 | 2010 | 244 | 0.310 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3725 | 0.290 |
Why?
|
Lipid Bilayers | 2 | 2008 | 383 | 0.270 |
Why?
|
Expert Testimony | 4 | 2021 | 361 | 0.260 |
Why?
|
Gramicidin | 1 | 2004 | 12 | 0.250 |
Why?
|
Sensitivity and Specificity | 10 | 2020 | 14661 | 0.240 |
Why?
|
Calcium-Binding Proteins | 2 | 2008 | 1067 | 0.240 |
Why?
|
Genomics | 3 | 2018 | 5795 | 0.230 |
Why?
|
Thermodynamics | 1 | 2005 | 599 | 0.230 |
Why?
|
Humans | 58 | 2024 | 760613 | 0.210 |
Why?
|
Inositol | 2 | 2021 | 215 | 0.200 |
Why?
|
Burns | 2 | 2010 | 1866 | 0.200 |
Why?
|
Adult | 24 | 2024 | 220007 | 0.200 |
Why?
|
Algorithms | 6 | 2016 | 13982 | 0.180 |
Why?
|
Electronics | 1 | 2021 | 315 | 0.180 |
Why?
|
Male | 26 | 2024 | 359718 | 0.170 |
Why?
|
Reproducibility of Results | 12 | 2021 | 20080 | 0.170 |
Why?
|
Female | 27 | 2024 | 391246 | 0.170 |
Why?
|
Brain Mapping | 1 | 2013 | 6569 | 0.150 |
Why?
|
Protein Structure, Secondary | 5 | 2008 | 1229 | 0.150 |
Why?
|
Phosphocreatine | 2 | 2016 | 261 | 0.150 |
Why?
|
Angiogenesis Inhibitors | 3 | 2021 | 2049 | 0.150 |
Why?
|
Radiation Injuries, Experimental | 1 | 2017 | 88 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 370 | 0.150 |
Why?
|
tau Proteins | 1 | 2008 | 2095 | 0.140 |
Why?
|
Macrophages | 2 | 2017 | 5745 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13627 | 0.140 |
Why?
|
Head Movements | 1 | 2017 | 152 | 0.140 |
Why?
|
Fibromyalgia | 1 | 2021 | 401 | 0.140 |
Why?
|
Protons | 3 | 2019 | 1114 | 0.130 |
Why?
|
Prospective Studies | 6 | 2024 | 54306 | 0.130 |
Why?
|
Mitochondria, Muscle | 1 | 2016 | 172 | 0.130 |
Why?
|
Head | 1 | 2021 | 922 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2020 | 556 | 0.120 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 628 | 0.120 |
Why?
|
Quinazolines | 2 | 2011 | 1363 | 0.120 |
Why?
|
Middle Aged | 18 | 2024 | 220359 | 0.120 |
Why?
|
Muscle, Skeletal | 3 | 2016 | 4924 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 916 | 0.100 |
Why?
|
Peptides | 1 | 2004 | 4354 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1899 | 0.100 |
Why?
|
Drug Monitoring | 1 | 2018 | 965 | 0.100 |
Why?
|
Biopsy | 4 | 2012 | 6771 | 0.100 |
Why?
|
Lasers | 1 | 2015 | 952 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2013 | 435 | 0.090 |
Why?
|
Tissue Distribution | 2 | 2011 | 2262 | 0.090 |
Why?
|
Computer Simulation | 4 | 2011 | 6218 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2414 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4899 | 0.090 |
Why?
|
Bone Marrow Transplantation | 1 | 2017 | 2693 | 0.090 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 994 | 0.080 |
Why?
|
Nitrogen Isotopes | 2 | 2005 | 85 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2015 | 11152 | 0.080 |
Why?
|
Regeneration | 1 | 2017 | 1506 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2015 | 2192 | 0.080 |
Why?
|
Carbon Isotopes | 2 | 2005 | 459 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1763 | 0.080 |
Why?
|
Circular Dichroism | 1 | 2008 | 348 | 0.070 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2008 | 128 | 0.070 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 848 | 0.070 |
Why?
|
Young Adult | 7 | 2020 | 58748 | 0.070 |
Why?
|
Glycine | 1 | 2010 | 662 | 0.070 |
Why?
|
Rhodopsin | 1 | 2007 | 203 | 0.070 |
Why?
|
Pseudomonas Infections | 1 | 2010 | 623 | 0.070 |
Why?
|
Photoaffinity Labels | 1 | 2005 | 85 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2869 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7587 | 0.060 |
Why?
|
Glutamic Acid | 2 | 2021 | 1167 | 0.060 |
Why?
|
Phenylalanine | 1 | 2005 | 365 | 0.060 |
Why?
|
Molecular Probes | 1 | 2005 | 313 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3800 | 0.060 |
Why?
|
Models, Chemical | 1 | 2005 | 614 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2017 | 2859 | 0.050 |
Why?
|
Computer Systems | 2 | 2016 | 470 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3520 | 0.050 |
Why?
|
Anisotropy | 1 | 2004 | 1278 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9278 | 0.050 |
Why?
|
Artificial Intelligence | 2 | 2012 | 2557 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9406 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5787 | 0.040 |
Why?
|
Epilepsy | 2 | 2012 | 3267 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4902 | 0.040 |
Why?
|
alpha-Synuclein | 1 | 2005 | 749 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 373 | 0.040 |
Why?
|
Misonidazole | 1 | 2018 | 33 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8512 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2020 | 453 | 0.040 |
Why?
|
Calibration | 1 | 2020 | 816 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5434 | 0.040 |
Why?
|
Movement | 2 | 2017 | 1474 | 0.040 |
Why?
|
Dipeptides | 1 | 2020 | 410 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2634 | 0.040 |
Why?
|
Cell Membrane | 1 | 2007 | 3682 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4319 | 0.040 |
Why?
|
Phosphorus Isotopes | 1 | 2016 | 124 | 0.040 |
Why?
|
Glutamine | 1 | 2020 | 576 | 0.030 |
Why?
|
Animals | 5 | 2017 | 167960 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29661 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2647 | 0.030 |
Why?
|
Equipment Failure | 1 | 2017 | 577 | 0.030 |
Why?
|
Physical Phenomena | 1 | 2014 | 48 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1904 | 0.030 |
Why?
|
Central Nervous System | 1 | 2021 | 1334 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 58980 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6465 | 0.030 |
Why?
|
Aged | 6 | 2020 | 169143 | 0.030 |
Why?
|
Motor Cortex | 1 | 2020 | 995 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2016 | 663 | 0.030 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 60 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2016 | 830 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.020 |
Why?
|
Mice | 3 | 2017 | 81209 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3568 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2016 | 1583 | 0.020 |
Why?
|
Phosphorus | 1 | 2011 | 333 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2013 | 5201 | 0.020 |
Why?
|
Rotation | 1 | 2011 | 514 | 0.020 |
Why?
|
Creatine | 1 | 2011 | 426 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2009 | 262 | 0.020 |
Why?
|
Monocytes | 1 | 2017 | 2575 | 0.020 |
Why?
|
Astrocytoma | 1 | 2012 | 775 | 0.020 |
Why?
|
Halobacteriaceae | 1 | 2007 | 1 | 0.020 |
Why?
|
Software | 1 | 2021 | 4419 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2008 | 8561 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2897 | 0.020 |
Why?
|
Leg | 1 | 2011 | 1091 | 0.020 |
Why?
|
Quantum Theory | 1 | 2005 | 68 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2005 | 291 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14494 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15286 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4925 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18137 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2005 | 617 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2505 | 0.010 |
Why?
|
Molecular Conformation | 1 | 2005 | 548 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22052 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 87809 | 0.010 |
Why?
|
Amino Acids | 1 | 2009 | 1714 | 0.010 |
Why?
|
Meningioma | 1 | 2012 | 1221 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2013 | 2733 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2014 | 2782 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14374 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 1895 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1902 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2698 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4169 | 0.010 |
Why?
|
Time Factors | 2 | 2011 | 40139 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3774 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10185 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6377 | 0.010 |
Why?
|
Protein Conformation | 1 | 2005 | 3970 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11070 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13312 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13451 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6316 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17624 | 0.010 |
Why?
|
Apoptosis | 1 | 2009 | 9497 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22020 | 0.010 |
Why?
|
Models, Biological | 1 | 2007 | 9468 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2013 | 80345 | 0.000 |
Why?
|